Evergreen, evidence-first explainers — how to read the data, source safely, and use the tools. Written for researchers who want the reasoning, not the hype.
Thinking about where to buy peptides? This guide explains how to vet a research-peptide seller on hard signals — third-party lab testing, certificates of analysis, reviews, and enforcement history — so you can tell a trusted source from a risky one.
A certificate of analysis (COA) is a lab document reporting a peptide batch’s identity and purity. Here’s how to read one, which tests matter, and the red flags that should make you walk away.
Not all evidence is equal. This guide explains the four evidence tiers used across the PeptidesHub compound database — from human randomized controlled trials down to theoretical mechanisms — and how to weigh them.
Reconstitution is just arithmetic: vial amount, water volume, and the resulting concentration. This guide walks through the formulas step by step so the numbers stop being mysterious. Math only — not medical advice.
GLOW is a blended peptide stack of GHK-Cu, BPC-157 and TB-500 marketed for skin and recovery. Here is what is actually in it, what the evidence shows for each component, and how to source it safely. Research and educational use only.
The Wolverine stack pairs BPC-157 and TB-500, two peptides popular in recovery circles. Here is what each one is, what the evidence supports, and how to source the pair safely. Research and educational use only.
KLOW adds KPV to the GLOW blend, combining KPV, GHK-Cu, BPC-157 and TB-500. Here is what each component is, what the evidence shows, and how to vet a source. Research and educational use only.
A peptide is a short chain of amino acids that acts as a signaling molecule in the body. This guide explains what peptides are, how research peptides differ from approved drugs, and how to read the evidence — in plain English. Research and educational use only.
Retatrutide is an investigational triple GIP/GLP-1/glucagon receptor agonist in phase 3 trials, watched closely in 2026 for its weight-loss data. Here is what it is, how it compares to tirzepatide and semaglutide, and why research-chemical sourcing is risky. Research and educational use only.
Longevity peptides like MOTS-c and Epitalon are marketed for anti-aging and mitochondrial health, but the human evidence is thin. Here is what each one is, what the research actually shows, and how to read the claims critically. Research and educational use only.
GLP-1 weight loss includes lean muscle, not just fat — a real concern with semaglutide, tirzepatide and retatrutide. Here is what the research shows about muscle loss, how much of it is lean mass, and the factors discussed for preserving it. Research and educational use only.
GHK-Cu is a copper peptide studied for skin firmness, wrinkles and hair. Topical cosmetic use has real human data; injectable systemic claims are largely preclinical. Here is what the research supports and how to source it. Research and educational use only.
CagriSema combines cagrilintide (an amylin analog) with semaglutide (a GLP-1 agonist) for weight loss. Here is what it is, how it differs from retatrutide, what the REDEFINE trials show, and its 2026 status. Research and educational use only.
BPC-157 is not FDA approved, has no published human trials, and in 2023 the FDA restricted its use in compounding. Here is its real 2026 legal status, what the evidence shows, and what that means for sourcing. Research and educational use only.